| 146.55 Delayed Data As of Aug 23 |  -3.84 / -2.55%Today’s Change | 98.23 Today|||52-Week Range 160.25 | +36.49% Year-to-Date |
| Has Masimo (MASI) Outpaced Other Medical Stocks This Year? Aug 19 / Zacks.com - Paid Partner Content |
| Previous close | 150.39 |
| Today’s open | 150.53 |
| Day’s range | 145.95 - 151.31 |
| Volume | 252,977 |
| Average volume (3 months) | 420,154 |
| Market cap | $8.1B |
| Earnings growth (last year) | +45.13% |
| Earnings growth (this year) | +3.98% |
| Earnings growth (next 5 years) | +14.95% |
| Revenue growth (last year) | +7.54% |
| P/E ratio | 41.9 |
| Price/Sales | 6.89 |
| Price/Book | 8.29 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVCRNovocure Ltd | -4.11 | -4.25% |
| VARVarian Medical Syste... | -2.12 | -1.96% |
| TNDMTandem Diabetes Care... | -0.78 | -1.15% |
| LIVNLivaNova PLC | -3.64 | -4.60% |
| Next reporting date | October 30, 2019 |
| EPS forecast (this quarter) | $0.73 |
| Annual revenue (last year) | $858.3M |
| Annual profit (last year) | $193.5M |
| Net profit margin | 22.55% |
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Joe E. Kiani |
Chief Operating Officer Bilal Muhsin |
Corporate headquarters Irvine, California |
